Changes in cerebral vascular reactivity and structure following prolonged exposure to high altitude in humans by Foster, Glen E. et al.
ORIGINAL RESEARCH
Changes in cerebral vascular reactivity and structure
following prolonged exposure to high altitude in humans
Glen E. Foster1,2, Jodie Davies-Thompson3, Paolo B. Dominelli2, Manraj K. S. Heran4, Joseph
Donnelly5, Gregory R. duManoir1, Philip N. Ainslie1, Alexander Rauscher6 & A. William Sheel2
1 Centre for Heart, Lung, and Vascular Health, School of Health and Exercise Science, University of British Columbia, Kelowna, Canada
2 School of Kinesiology, University of British Columbia, Vancouver, Canada
3 Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, Canada
4 Diagnostic and Therapeutic Neuroradiology, Vancouver General Hospital, University of British Columbia, Vancouver, Canada
5 Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
6 Department of Radiology, UBC MRI Research Centre, University of British Columbia, Vancouver, Canada
Keywords
Cerebral atrophy, cerebral vascular reactivity,
high altitude.
Correspondence
Glen E. Foster, School of Health and Exercise
Science, Faculty of Health and Social
Development, University of British Columbia,
3333 University Way, Kelowna, BC, V1V
1V7, Canada.
Tel: 250-807-8224
Fax: 250-807-9865
E-mail: glen.foster@ubc.ca
Funding Information
This study was supported in part by the
Natural Sciences and Engineering Research
Council (NSERC) of Canada (A.W. Sheel;
#249990) and a Canada Research Chair to
P.N. Ainslie. This study was carried out within
the framework of the Ev-K2-CNR Project in
collaboration with Nepal Academy of Science
and Technology as foreseen in the
Memorandum of Understanding between
Nepal and Italy, and thanks to a contribution
from the Italian National Research Council.
G.E. Foster was supported in part by: (1) a
postdoctoral fellowship from NSERC; (2) a
focus-on-stroke research fellowship funded
by the Heart and Stroke Foundation of
Canada, the Canadian Stroke Network, the
Canadian Institutes of Health Research (CIHR)
Institute of Circulatory and Respiratory Health
and the CIHR Institute of Aging; and (3) a
research award from the Michael Smith
Foundation for Health Research. A. Rauscher
is supported by a CIHR New Investigator
Award. J. Donnelly is supported by a Woolf
Fisher scholarship.
Abstract
Although high-altitude exposure can lead to neurocognitive impairment, even
upon return to sea level, it remains unclear the extent to which brain volume
and regional cerebral vascular reactivity (CVR) are altered following high-alti-
tude exposure. The purpose of this study was to simultaneously determine the
effect of 3 weeks at 5050 m on: (1) structural brain alterations; and (2) regio-
nal CVR after returning to sea level for 1 week. Healthy human volunteers
(n = 6) underwent baseline and follow-up structural and functional magnetic
resonance imaging (MRI) at rest and during a CVR protocol (end-tidal PCO2
reduced by 10, 5 and increased by +5, +10, and +15 mmHg from base-
line). CVR maps (% mmHg1) were generated using BOLD MRI and brain
volumes were estimated. Following return to sea level, whole-brain volume
and gray matter volume was reduced by 0.4  0.3% (P < 0.01) and
2.6  1.0% (P < 0.001), respectively; white matter was unchanged. Global
gray matter CVR and white matter CVR were unchanged following return to
sea level, but CVR was selectively increased (P < 0.05) in the brainstem
(+30  12%), hippocampus (+12  3%), and thalamus (+10  3%). These
changes were the result of improvement and/or reversal of negative CVR to
positive CVR in these regions. Three weeks of high-altitude exposure is
reflected in loss of gray matter volume and improvements in negative CVR.
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Introduction
Ascent to high altitude can result in a decrement in neu-
ronal processing, including impairment of arithmetic,
memory, language, perception, learning, cognitive flexibil-
ity, and psychomotor skills (Wilson et al. 2009; Ainslie
et al. 2014). Such decrements in cognitive functioning are
implicated in a significant number of deaths above
8000 m (Firth et al. 2008). The underlying pathophysio-
logical mechanisms contributing to neurocognitive deficit
when sea-level residents are exposed to high altitude
remain unknown, but may relate to impaired cerebrovas-
cular function and/or neuronal apoptosis (evidenced by
loss of gray and/or white matter tissue) even following
return to sea level. For example, cognitive deficits are
linked to structural brain alterations clinically, and mag-
netic resonance imaging (MRI) based measurements of
regional gray matter volume are a close surrogate for neu-
ronal loss (Teipel et al. 2013). Furthermore, impaired
cerebral vascular reactivity can disturb oxygen delivery
and is predictive of stroke risk in some clinical scenarios
(Yonas et al. 1993).
Although acute exposure to hypoxia (hours to days)
can lead to brain swelling (Morocz et al. 2001; Dubowitz
et al. 2009; Rupp et al. 2014), longer term high-altitude
exposure at elevations greater than 5000 m result in neu-
ronal apoptosis in regions of the brain including cortex,
hippocampus, and striatum (Maiti et al. 2008). Other
structural brain alterations following exposure to high
altitude may include an increase in the number of white
matter hyperintensities (WMHI) [reviewed in: McGuire
et al. (2014)], and gray and white matter atrophy (Gar-
rido et al. 1993; Paola et al. 2008), contributing to a
reduction in total brain volume. Hemosiderin deposits
(i.e., microhemorrhages) have also been reported in sub-
jects who have experienced high-altitude cerebral edema
(Schommer et al. 2013). Cortical atrophy in humans is
linked to impaired cognitive function and has been sug-
gested to occur with chronic high-altitude exposure
(Fayed et al. 2006). Though previous reports (Garrido
et al. 1993, 1995; Fayed et al. 2006; Paola et al. 2008;
McGuire et al. 2012, 2013; Zhang et al. 2012, 2013;
Schommer et al. 2013) have aimed to study changes in
brain volume, gray and white matter volume, WMHI,
and hemosiderin deposits following high-altitude expo-
sure the results have been inconsistent. For example,
Zhang et al. (Zhang et al. 2012) studied 14 mountaineers
before and following ascent to 6206 m and found disrup-
tion of white matter fiber integrity but could not replicate
the changes in gray matter observed by others (Paola
et al. 2008; Yan et al. 2010; Zhang et al. 2013). The lack
of agreement between studies could be due to numerous
factors including altitude (mild, moderate, or severe),
length of stay (acute vs. chronic), time of follow-up mea-
surement (days to years), or repeated altitude exposure
between measurements (impact of repeat exposure and/or
intermittent hypoxia). In an attempt to reconcile such
differences and build upon previous work, we employed a
longitudinal study design, at a moderate altitude often
travelled to by trekkers, and made pre and posttest mea-
surements in close succession to limit extraneous factors.
Cerebrovascular reactivity (CVR) to changes in CO2 is
another important metric of the functional capacity of
cerebral blood vessels. Cerebral blood flow increases with
hypercapnia and decreases with hypocapnia. A reduction
in the magnitude of CVR to changes in CO2 has been
suggested to indicate impaired vascular function and a
reversal of CVR (i.e., negative CVR); such changes are
reflective of vascular steal (Sobczyk et al. 2014). Negative
CVR and/or vascular steal indicate that in response to a
global vasodilatory stimulus, regional blood flow is
decreased. There is some evidence in humans that CVR is
either unchanged (Willie et al. 2015), reduced (Villien
et al. 2013) or enhanced at high altitude (Fan et al. 2010,
2014; Fl€uck et al. 2015). Differences in the method to
assess CVR and inaccuracies due to changes in middle
cerebral artery (MCA) diameter (Coverdale et al. 2014)
may explain between-study differences. However, there
has been little emphasis on the regional CVR response
following return to sea level from high altitude where
long-lasting effects of high-altitude exposure may be
observed. Recently, Villien et al. (2013), using an arterial
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spin-labeling magnetic resonance imaging (MRI)
approach, showed that CVR in the MCA territory is
reduced immediately following descent to sea level follow-
ing 6 days at 4300 m. However, measurements were made
immediately following descent from high altitude where
acid-base balance of the blood and cerebral spinal fluid
make interpretation difficult. For example, the end-tidal
PCO2 differed between baseline and follow-up measure-
ments by nearly 8 mmHg. The question arises whether or
not the reduction in CVR would have remained several
days later with normalization of arterial pH and PCO2?
In addition, although studies show that cortical and ante-
rior/posterior blood flow differences exist in the response
of the brain to exposure to normobaric (Binks et al.
2008; Willie et al. 2012; Lewis et al. 2014b) or hypobaric
hypoxia (Subudhi et al. 2014), it remains unclear if regio-
nal CVR differences assessed by blood oxygen level-
dependent MRI remain upon return to sea level once
acid-base balance has been restored and the lasting effects
of high-altitude exposure can be observed.
The purpose of this investigation was to simultaneously
determine the effect of 3 weeks at 5050 m on: (1) struc-
tural brain alterations; and (2) regional cerebral vascular
reactivity after returning to sea level for 1 week. We
hypothesized that 1-week following exposure to high alti-
tude, (1) overall brain volume would be reduced due to a
decrease in gray matter volume; (2) the number of
WMHI and/or microhemorrhages would remain
unchanged due to the controlled ascent profile; and (3)
the CVR would be reduced.
Materials and Methods
Ethical approval
All experimental procedures and protocols were approved
by the University of British Columbia Clinical Research
Ethics Board and conformed to the standards set by the
Declaration of Helsinki, and all subjects provided written
informed consent prior to participation.
Participants
Healthy human volunteers (n = 7, two female) were stud-
ied from a subgroup of participants traveling to the Ev-
K2-CNR Pyramid Laboratory (5050 m above sea level) as
part of the University of British Columbia’s International
Research Expedition (Foster et al. 2014; Lewis et al.
2014a; Willie et al. 2014). All data presented herein is
original and has not been published elsewhere.
All subjects were screened for cardiopulmonary disease
by 12-lead electrocardiogram, pulmonary function testing,
resting blood pressure measurements, and a maximal
exercise test. Subjects were excluded if they had a history
of smoking, were hypertensive (resting systolic >140
mmHg; diastolic >90 mmHg), or had poor pulmonary
function based on spirometry measurements [i.e., forced
expiratory volume in 1 sec: forced vital capacity (FEV1/
FVC) ratio less than 0.75]. In addition, all subjects com-
pleted a screening form for MRI contraindications. Sub-
jects refrained from caffeine (>12 h), alcohol and exercise
(>24 h) prior to experimental measurements.
Experimental protocol
All subjects attended three experimental testing sessions at
sea level. During the first visit, subjects were screened for
study inclusion and were familiarized with the breathing
circuit and breathing tests that were to be subsequently
conducted inside the MRI suite. Visit two and three were
identical and involved structural and functional imaging
of the brain using MRI at rest and during a CVR test to
hypo/hypercapnia. The CVR test involved two, two-min-
ute steps of hypocapnia [end-tidal partial pressure of CO2
(PETCO2) reduced by 10 and 5 mmHg respective to base-
line by voluntary hyperventilation] and three, two-minute
steps of hypercapnia (PETCO2 increased by 5, 10, and
15 mmHg respective to baseline during eupnea). During
the CO2 test the end-tidal partial pressure of O2 (PETO2)
was clamped at 100 mmHg for all trials. This protocol
has been used previously to assess CVR by Doppler ultra-
sound of both intracranial and neck vessels including the
study of cerebral blood flow regulation on this expedition
(Willie et al. 2015).
Between the second and third testing sessions, subjects
were involved in a research expedition to the Ev-K2-CNR
Pyramid Laboratory. The trek involved 1 week in Kath-
mandu (elevation: 1400 m) and an 8-day trek from Lukla
(elevation: 2860 m) to the Pyramid Laboratory where the
subjects remained for 3 weeks prior to descending to
Kathmandu over a 4-day period. The trekking profile and
the anterior/posterior changes in cerebral blood flow
(measured using ultrasound methods) during this trek
have previously been reported (Willie et al. 2014). The
second and third testing session took place in Vancouver
at sea level 1 day prior to departure to Nepal and 1 week
following return from Nepal. While at the Pyramid Labo-
ratory, the subjects were involved in various research pro-
jects aimed at understanding the cerebral, cardiac, and
pulmonary response to high altitude (Foster et al. 2014;
Willie et al. 2014). During the 8-day trek to the labora-
tory, subjects ingested acetazolamide (125 mg three times
daily) to aid in acclimatization and minimize the risk and
severity of acute mountain sickness. The Lake Louise and
environmental symptoms – cerebral symptoms question-
naires were used to assess acute mountain sickness
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(Sampson et al. 1983). Acetazolamide ingestion was with-
drawn 24 h prior to arriving at the pyramid laboratory. A
physician was present to manage patient symptoms and
conservatively prescribe treatment where necessary.
Experimental techniques
Magnetic resonance imaging
After the subject completed the screening questionnaires
for MRI they were instrumented with a facemask and
breathing apparatus and placed inside a 3.0 tesla MRI
scanner (Philips Achieva) in the supine position. Scans
were conducted using an 8-channel SENSE head coil in
the following order: T1-weighted imaging for anatomical
structures and volumetric analyses, multi echo susceptibil-
ity-weighted imaging (SWI)(Denk and Rauscher 2010) to
determine microhemorrhages (five echoes, TE1 = 6 msec,
echo = 6 msec; TR = 34 msec; voxel size = 0.5 9 0.5 9
1 mm3), and 3D fluid attenuated inversion recovery
(FLAIR) imaging for WMHI (TR = 8000 msec, TI = 2400
msec, TE = 156 msec, voxel size = 1 9 1 9 1 mm3).
Blood oxygen level-dependent (BOLD) imaging for CVR
to changes in arterial CO2 was performed using T2*-
weighted echo planar imaging with 36 interleaved axial
slices (TR = 2000 msec, TE = 30 msec, FOV = 240 9
216 mm, 3 mm thickness with 1 mm gap, voxel size = 3
9 3 mm, 128 mm reconstruction matrix, reconstructed
voxel size 1.88 9 1.6 mm). FLAIR and SWI were read for
WMHI and microhemorrhages by an experienced neuro-
radiologist (MH) who was blinded to subject and the
experimental condition.
Respiratory control and measurements
Respiratory and cardiovascular parameters were acquired
at 200 Hz using an analog-to-digital converter (PL3504,
ADinstruments, Colorado Springs) interfaced with a per-
sonal computer and analyzed using commercially avail-
able software (LabChart, ADinstruments, Colorado
Springs). Throughout resting and CO2 testing procedures
subjects breathed through a facemask and two-way nonre-
breathing valve. Respired gas concentrations were sampled
at the mouth and analyzed for PO2 and PCO2 (model
#17620 and #17630, VacuMed, Ventura). Respiratory flow
was measured at the mouth using a pneumotachograph
(HR 800L, HansRudolph, Shawnee). PETO2, PETCO2,
inspiratory (VTI), and expiratory tidal volume (VTE) were
determined for each breath online using specifically
designed software (Labview 13.0, National Instruments,
Austin). Arterial oxyhemoglobin saturation (SpO2) was
measured by finger pulse oximetry (7500FO, Nonin Med-
ical Inc, Plymouth). PETO2 and PETCO2 were controlled
by a portable end-tidal forcing system designed specifi-
cally for use in the MRI suite. The end-tidal gas control
system uses independent gas solenoid valves for O2, CO2,
and N2 and controls the volume of each gas being deliv-
ered to the inspiratory reservoir through a mixing and
humidification chamber. PETCO2 using this gas control
system is within 2.1  0.5 mmHg of arterial PCO2 at
baseline and during hypercapnia (Tymko et al. 2015).
Resting parameters were acquired with the subject in the
supine position inside the MRI scanner immediately
before conducting the CVR test.
MRI analysis
Two time-point percentage brain volume change (PBVC)
was estimated with SIENA (Smith et al. 2002), part of FSL
(FMRIB’s Software Library, www.fmrib.ox.ac.uk/fsl)
(Smith et al. 2004). SIENA extracts brain and skull images
from the two time-point whole-head input data and subse-
quently aligns the two images with each other (Jenkinson
et al. 2002; Smith et al. 2002). Next, tissue-type segmenta-
tion is carried out in order to find brain/nonbrain edge
points, and then perpendicular edge displacement between
the two time points is estimated at these edges (Zhang et al.
2001). Finally, the mean edge displacement is converted
into a global estimate of PBVC between the two time
points. The global estimate of PBVC between the two time
points was assessed statistically by one sample t-test refer-
enced to zero percent change. Global gray matter and white
matter volume were estimated from partial volume esti-
mates from the normalized segmented output from SIENA
and were used to generate gray and white matter masks for
extraction of CVR data (see below). Paired t-tests were used
to determine if gray and white matter volume differed with
exposure to high altitude. Finally, focal gray matter atrophy
was analyzed using FSL’s optimized voxel-based morphom-
etry protocol (Smith et al. 2004). A voxel-wise general lin-
ear model was applied using permutation-based
nonparametric testing, correcting for multiple comparisons
across space. z-statistic maps were generated and consid-
ered significant at a resel-corrected P-value of 0.05. The
resel correction uses a principle similar to Gaussian ran-
dom field theory to estimate the number of independent
samples (resels) within a dataset (Worsley et al. 1998), and
is therefore less conservative than a Bonferroni correction.
BOLD data processing was carried out using FEAT
(FMRI Expert Analysis Tool, Version 6.0), part of FSL.
Registration to individual participants T1-weighted
anatomical image and to standard (MNI) space was car-
ried out using FLIRT (Jenkinson et al. 2002). Motion
correction was applied using MCFLIRT (Jenkinson et al.
2002), followed by slice-timing correction, spatial
smoothing (a Gaussian, FWHM 6 mm), and high-pass
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temporal filtering (Gaussian-weighted least-squares
straight line fitting, with sigma = 0.5sec).
Time-series statistical analysis was carried out using
FILM with local autocorrelation correction (Woolrich
et al. 2001). PETCO2 and SpO2 were entered as explanatory
and nuisance variables, respectively. For each subject,
PETCO2 and PETO2 were time corrected for sample and cir-
culation delay by cross-correlation (Poublanc et al. 2013)
with whole-brain BOLD time course prior to modeling and
statistical analysis for both baseline and follow-up condi-
tions. For general linear modeling, SpO2 was calculated
from PETO2 based on the equations defined by Severing-
haus (Severinghaus 1979) to correct for the circulatory
delay. PETCO2 parameter estimates were converted to
percent signal change and CVR maps (% mmHg1) were
generated by indexing against the change in PETCO2.
Average CVR was extracted separately for gray matter,
white matter, and anatomical regions of interest from the
Harvard-Oxford Subcortical Structural Atlas. Since areas
of negative CVR could influence the overall CVR in each
anatomical structure, further analysis was conducted on
only those voxels showing a positive CVR and a resel-cor-
rected z-statistic with P < 0.05 from each region. This
was then repeated for regions showing a negative CVR.
At follow-up the data were extracted from the same
regions to determine how high-altitude exposure affected
regions of negative and/or positive CVR.
Statistical analysis
A two-by-two repeated measures analysis of variance was
used to determine the effect of high-altitude hypoxia on the
left and right hemisphere structures. A paired t-test was
used for structures such as the brainstem, which was not
categorized by hemispheres. A two-by-two repeated mea-
sures analysis of variance was also used to determine the
effect of high-altitude exposure on areas of positive and
negative CVR. In all cases, when significant F-ratios were
uncovered, Tukey’s HSD post hoc analysis was conducted.
Statistical tests were conducted using commercially avail-
able software (Statistica V.7.0, Statsoft Inc., Tulsa). Respira-
tory parameters were compared at rest (paired t-test) and
throughout the vascular reactivity test (repeated measures
ANOVA). In all cases P < 0.05 was considered statistically
significant. Values are presented as means  SE.
Results
Subjects
One female subject was excluded from posttesting because
she was prematurely evacuated from our high-altitude
laboratory for medical reasons unrelated to experimental
testing. Consequently, six subjects are included in the
analyses reported here. Six subjects (age = 31.8  3.7
years; BMI = 27.0  3.6 kg m2) completed all experi-
mental sessions including pre- and post-MRI measure-
ments. Subjects had normal resting pulmonary function
(FEV1/FVC = 83.0  4.9% or 107  5% predicted), car-
diovascular health (resting MAP = 89  3 mmHg;
HR = 62  11 beats min1) and met the study inclu-
sion/exclusion criteria. During the trek to high altitude
and during the first few days at 5050 m, subjects were
monitored for acute mountain sickness. All subjects
developed symptoms of acute mountain sickness with a
Lake Louise acute mountain sickness score >3. However,
two male subjects had symptoms necessitating interven-
tion including 2 h of supplemental oxygen (n = 1; within
6 h of arrival at 5050 m) and intravenous dexamethasone
(n = 1; required after 1 week at 5050 m). The remaining
subjects experienced mild symptoms of acute mountain
sickness that did not warrant treatment.
Volumetric analyses
Brain volume was reduced by an estimated 0.4  0.3%
(P < 0.01) following exposure to high altitude. This
response ranged from a 0.21 to 1.00% estimated per-
cent brain volume change. Gray matter density, analyzed
by voxel-based morphometry, did not detect altitude
induced focal changes. However, global volumetric
calculations revealed a reduction in gray matter
(2.6  1.0%; P < 0.001) but not white matter
(1.3  0.7%; P = 0.14). Table 1 displays the absolute
and percent change in gray matter and white matter vol-
ume for each subject.
Cerebral vascular reactivity
Resting breathing frequency, tidal volume, minute ventila-
tion, PETO2, PETCO2, and SpO2 were acquired from the
subject inside the MRI scanner (Table 2). Subjects were
in a similar resting state with normal respiratory gases.
Figure 1 displays the group mean time course of PETCO2,
PETO2, minute ventilation, and the resultant %BOLD
response of the brainstem during the CVR measurement
before and following exposure to high-altitude hypoxia.
The steps in PETCO2 were the same between conditions
and PETO2 was held constant throughout both tests. Fig-
ure 2 displays the resultant CVR and z-statistic maps for
one representative subject at follow-up. The number of
significant voxels in the z-statistic map suggests that over
the range of PETCO2 studied the BOLD response is suit-
ably linear. It can also be noted that gray matter responds
to a much greater degree than white matter (see Fig. 2).
Table 3 provides an individual account of CVR for white
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2015 | Vol. 3 | Iss. 12 | e12647
Page 5
G. E. Foster et al. Functional Brain Adaptations to High Altitude
and gray matter and highlights the nearly twofold differ-
ence (P < 0.01) in gray and white matter CVR (see also
Fig. 3).
Following exposure to high-altitude hypoxia, individual
subjects displayed focal increases in CVR. However, these
areas did not colocalize between subjects. To determine
regional changes in CVR, masks were created for all
structures contained within the Harvard-Oxford Subcorti-
cal Structural Atlas. In addition, gray and white matter
masks were created. Figure 3 shows the average CVR for
all subjects from each of these regions. CVR was greatest
in gray matter and lowest in white matter. Generally, the
brainstem, amygdala, hippocampus, and the thalamus
had the highest CVR compared to other structures. There
were no differences between the CVR in left and right
hemispheres except for the putamen that had a greater
CVR in the left hemisphere (P < 0.05).
Following 3 weeks at high altitude, CVR was increased
in the brainstem, hippocampus, and thalamus. After seg-
menting the structures into significant (i.e., P < 0.05)
voxels of positive and negative reactivity during the pret-
est, we determined that this was the result of an improve-
ment and/or reversal of negative reactivity to positive
(Fig. 4). As a result, regions of positive reactivity during
the pretest maintained their reactivity, whereas regions of
negative reactivity during the pretest were substantially
reduced in size and became positive on average during
the posttest. This result was most notable for gray matter,
white matter, brainstem, nucleus accumbens, caudate, and
hippocampus. The pallidum, putamen, and thalamus
often did not have any significant voxels of negative reac-
tivity and hence statistical testing could not be conducted
for these regions.
Focal areas of negative reactivity were often found in
subjects at baseline. Figure 5 shows a sagittal slice CVR
map and z-statistic map from before (A) and after high-
altitude exposure in a representative subject (B). Of note
are the regions of negative reactivity in the posterior-right
hemisphere and the frontal lobe region. Following expo-
sure to high altitude, the negative reactivity in the frontal
lobe had completely normalized and negative reactivity in
the posterior-right hemisphere had decreased in size. Fig-
ure 5C displays the fractional frequency distribution of
CVR for the same subject at baseline and follow-up. Note
the number of voxels responding in the negative range is
substantially reduced at follow-up and contributes to the
rightward shift of the mean CVR (dotted lines in figure).
Microhemorrhages and white matter
hyperintensities
Due to technical problems, microhemorrhages and
WMHIs could not be assessed in one subject during his
pretest measurement. As a result, only five subjects are
reported for microhemorrhages and WMHIs. No micro-
hemorrhages were detected before or after exposure to
high altitude in any subject. WMHIs were detected in
most subjects at baseline and follow-up in subcortical
structures (n = 4) and in some subjects in deep white
matter structures (n = 2) (see Table 2). In one subject,
Table 1. Gray matter and white matter volumetric analysis and white matter hyperintensities (WMHI) before (Pre) and after (Post) exposure
to high altitude for all subjects
Subjects
Gray matter (mL) White matter (mL) WMHI (#)
Pre Post % Change Pre Post % Change Pre Post
1 733 718 2.1 666 652 2.0 3 6
2 569 544 4.3 509 490 3.7 1 1
3 653 631 3.4 614 623 +1.5 3 4
4 686 670 2.4 659 659 0.0 38 37
5 701 689 1.6 643 633 1.5 – –
6 667 653 2.0 601 590 1.8 0 0
Mean (SE) 668 (23) 651 (25) 2.6 (0.4)* 615 (24) 608 (25) 1.3 (0.7)
*P < 0.001.
Table 2. Subject baseline characteristics before (pre) and after
(Post) exposure to high altitude
Pre Post P
Fb, breaths min
1 12.6 (1.6) 13.9 (1.0) 0.39
VT, L 1.0 (0.1) 0.94 (0.1) 0.54
V̇E, L min
1 11.0 (1.1) 12.7 (0.5) 0.18
PETO2, mmHg 101.8 (1.8) 105.6 (2.0) 0.27
PETCO2, mmHg 41.4 (1.2) 39.5 (0.7) 0.13
SpO2, % 96.4 (0.3) 97.1 (0.3) 0.10
Values are mean (SE). Fb, breathing frequency; VT, tidal volume;
V̇E, minute ventilation; PETO2, end-tidal partial pressure of oxygen;
PETCO2, end-tidal partial pressure of carbon dioxide; SpO2, arterial
oxyhemoglobin saturation.
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WMHI were detected in the corpus callosum. WMHI
data were heavily skewed as one subject had a total of
37–38 lesions at baseline and follow-up. As a result
WMHI data are reported as the median  interquartile
range (IQR). All WMHI (subcortical and deep) were
pooled and found to change very little with 3 weeks of
exposure to high altitude (Pre: 3  2; Post: 4  5;
median  IQR).
Discussion
This is the first study to simultaneously examine the last-
ing effects of 3 weeks of high-altitude exposure on cere-
bral structure and vascular reactivity to CO2 in a
controlled prospective and longitudinal study design. The
major findings from this investigation are threefold. First,
exposure to 5050 m for 3 weeks contributes to a consis-
tent and measureable reduction in brain volume that can
be attributed to gray matter atrophy. Second, regions of
vascular steal (i.e., negative CVR) were detected in other-
wise healthy subjects at baseline. Finally, regions of the
brain responding with a positive BOLD-PETCO2 relation-
ship (i.e., positive CVR) were unaffected by high-altitude
exposure, whereas regions of the brain responding with
an inverse BOLD-PETCO2 relationship (i.e., negative
CVR) improved following high-altitude exposure.
Effects of 3 weeks at 5050 m on cerebral
structure
We observed a decline in gray matter volume of
2.6  0.4% following 3 weeks at high altitude which
exceeds the normal annual rate of decline of 0.83% yr1
(Crivello et al. 2014) and provides confidence in the
observed effect. Our results are consistent with findings in
nine elite mountain climbers before and following expedi-
tions to even greater altitudes without the use of supple-
mental oxygen (>6500 m) (Paola et al. 2008). Here,
climbers were found to have reduced gray matter density/
volume in the left angular gyrus, a region of brain associ-
ated with cognitive planning of movement. Although
climbers had reduced white matter volume in the left
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Figure 1. Group mean ventilatory and cerebral vascular response to the vascular reactivity test evoked by stepwise changes in CO2 before
(PRE) and after (POST) exposure to high-altitude hypoxia. % BOLD is displayed as the mean BOLD signal for the brainstem for the entire group
(n = 6) at 2 sec intervals, whereas the remaining data points are displayed as 30 sec mean  SE for the group (n = 6). The vertical dotted lines
define each step change in CO2. PETCO2, end-tidal partial pressure of carbon dioxide; PETO2, end-tidal partial pressure of oxygen; V̇E, minute
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pyramidal tract near the primary and supplementary
motor cortex compared to controls, white matter loss was
unchanged following the expedition. Consistent with this
finding, we also found no change in white matter volume;
however, rather than localized effects we found a global
reduction in gray matter volume.
We found gray matter tissue loss 1 week following
return to sea level compared to baseline. Previous reports
suggest that neurotoxicity may be delayed or long-lasting
(Shukitt-Hale et al. 1996). In one report, rats were
exposed to chronic hypoxia (5500 m and 6400 m) for
4 days and were sacrificed at different intervals between
72 and 144 h before conducting a histologic assessment
of cell degeneration and death (Shukitt-Hale et al. 1996).
Cell damage was greater the longer the time following
exposure to hypoxia. This delay in cell damage suggests
that by delaying our post brain scan by 1 week may have
contributed to an even greater loss of gray matter tissue
compared to other studies which aimed to conduct brain
scans as quickly as possible following high-altitude expo-
sure.
With acute exposure to hypoxia (FiO2 = 0.12, a nor-
mobaric altitude approximating 5000 m), brain swelling
in the white matter is identified between 6 and 16 h and
can be exacerbated by exercise (Rupp et al. 2014). Unfor-
tunately, less is known with respect to white matter adap-
tations following high-altitude acclimatization and return
to sea level. One longitudinal study of 14 mountaineers
was unable to detect any gray matter deficits before and
following an acute ascent to 6206 m but they did detect a
A
B
Figure 2. (A) Whole-brain cerebral vascular reactivity map and (B) z-statistic map resel-corrected to P < 0.05 for one representative subject.
The z-statistic provides a measure of how well the general linear model fits the BOLD signal to PETCO2 and thus illustrates a strong linear
relationship between BOLD and PETCO2.
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disruption of white matter fiber integrity using tract-
based spatial statistics of white matter fractional aniso-
tropy (Zhang et al. 2012). Although we cannot confirm a
disruption of white matter fiber integrity from our MRI
measures, our results do suggest that white matter volume
remains unchanged following return to sea level after
spending 3 weeks at 5050 m. While it is possible that our
study is underpowered to detect white matter changes,
the 7-mL change we observed over a 3-week span at high
altitude only modestly exceeds the normal annual rate of
decline in white matter (mean  SEM: 4.54  0.19 mL
[Driscoll et al. 2009]). We did not detect any new WMHI
or microhemorrhages. The latter is perhaps not surprising
as such reports come from subjects who have experienced
severe high-altitude cerebral edema which none of our
subjects had (Schommer et al. 2013). Though it is inter-
esting to note that the single subject with the greatest
number of WMHI also has had many years of experience
in high-altitude environments.
Effects of 3 weeks at 5050 m on regional
CVR
We examined for the first time the effect that exposure
to 5050 m had on CVR throughout different regions of
the brain including gray matter, white matter, brain-
stem, nucleus accumbens, amygdala, caudate, hippocam-
pus, pallidum, putamen, and thalamus (Fig. 3). Across
these regions of the brain, CVR varies from its lowest
reactivity in white matter tissue to its highest reactivity
in gray matter tissue, with the exception of the thala-
mus, which had a CVR slightly greater than that of
pure gray matter tissue. In addition to the variability
throughout each region of the brain, we also observed
some degree of variation between the hemispheres. The
differences in CVR throughout these functional units of
the brain are likely attributable to differences in vascu-
larity, pH sensitivity, and metabolic needs. For example,
the brainstem and thalamus are highly sensitive to CO2,
and the maintenance of tissue pH in these regions is
important for the control of respiration, and includes
chemosensitive neurons in the brainstem and neurons
encoding the sensory and affective components of respi-
ration (Chen et al. 1991). Thus, the enhanced CVR in
the thalamus may be a function of not only the global
CO2 sensitivity of the vasculature in this region but also
the result of increased metabolism linked to the role of
the thalamus in relaying information pertaining to respi-
ratory sensations and respiratory drive (Chen et al.
1991). Interestingly, the brainstem and thalamus are
believed to be phylogenetically older regions of the
brain and hence may be more sensitive to hypoxia
(Binks et al. 2008).
The spatial heterogeneity of CVR remained following
exposure to high altitude; however, most regions of the
brain had a slight increase in CVR reaching significance
in the brainstem, hippocampus, and thalamus (Fig. 3).
Our findings are in contrast to Villien et al. (2013) who
used arterial spin labeling MRI to assess CVR in the
MCA territory in healthy humans before and following
6 days at 4350 m. In addition, they made measurements
of CVR while at high altitude using transcranial Doppler
ultrasound of the MCA. Similar to their high-altitude
measurements they found that CVR was reduced follow-
ing return to sea level. However, measurements were
made within 6 h following return to sea level where sig-
nificant ventilatory responsiveness, hypocapnia, and
hematologic adaptations make comparison to our study
difficult. Thus, we suggest that 1-week following return to
sea level might be an appropriate time point for posttest-
ing in the MRI since arterial PCO2 has normalized. Fur-
thermore, the use of end-tidal forcing provides a
methodology for controlling arterial blood gases indepen-
dent of ventilation such that the stimulus for cerebral
blood flow reactivity is consistent (Fierstra et al. 2013).
Such devices reduce the variability in the BOLD signal
and cerebral blood flow by reducing the breath-by-breath
fluctuations in arterial PO2 and PCO2 (Chang and Glover
Table 3. Gray matter and white matter cerebral vascular reactivity before (Pre) and after (Post) exposure to high altitude for all subjects
Subjects
Gray matter CVR (% mmHg1) White Matter CVR (% mmHg1)
Pre Post % Change Pre Post % Change
1 0.30 0.39 +31.5 0.27 0.20 25.8
2 0.34 0.42 +21.3 0.19 0.21 +8.8
3 0.27 0.31 +15.2 0.15 0.18 +20.6
4 0.31 0.23 24.3 0.12 0.16 +28.9
5 0.33 0.41 +24.8 0.19 0.22 +16.5
6 0.31 0.32 +3.1 0.17 0.15 7.1
Mean (SE) 0.31* (0.01) 0.35* (0.03) +11.9 (8.24) 0.18 (0.02) 0.19 (0.01) +6.98 (8.24)
*P < 0.01 compared to respective white matter CVR.
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2009), reduce the distortion of CVR by the CO2-induced
changes in PETO2 (Prisman et al. 2007), and can protect
against the variability in arterial PCO2 between subjects
due to differences in chemosensitivity.
The importance of delineating negative and
positive CVR
The frequency distribution of CVR in healthy subjects
illustrates a normal distribution including a significant
proportion of negative voxels (Sobczyk et al. 2014). The
negative voxels represent regions of the brain with an
inverse response to CO2 and suggests a reduction in brain
blood flow despite the presence of a global dilator stimu-
lus. On the basis of this finding, we felt it necessary to
dichotomize each anatomical region of the brain into
regions of positive and negative CVR at baseline. In doing
so, we were able to determine if a change in negative
CVR was directly responsible for the increase in CVR we
observed in the brainstem, hippocampus, and thalamus.
Brainstem All
Accumbens
Left
Right
Amygdala
Left
Right
Caudate
Left
Right
Hippocampus
Left
Right
Pallidum
Left
Right
Putamen
Left
Right
CVR (%/mmHg)
0.0 0.1 0.2 0.3 0.4 0.5
Thalamus
Left
Right
White matter All
Grey matter All
Pre
Post
*
**
**
†
Figure 3. Displays the cerebral vascular reactivity (CVR) of different subcortical structures before (Pre) and after (Post) exposure to high-altitude
hypoxia. Where appropriate structures have been separated into left and right hemispheres. Values are mean  SE. *P < 0.05 Pre versus Post;
**P < 0.01 Pre versus Post; †P < 0.05 Left versus Right.
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Figure 4 illustrates that regions of positive CVR were
unaffected by 3 weeks at 5050 m, whereas the regions of
negative CVR gained a significant degree of positive reac-
tivity and contributed entirely to each regions increase in
CVR.
Implications of negative vascular reactivity
in otherwise healthy volunteers
While there is evidence to suggest that reduced CVR and
vascular steal is associated with enhanced risk of stroke
Brainstem
–CVR
+CVR
Accumbens
–CVR
+CVR
Amygdala
–CVR
+CVR
Caudate
–CVR
+CVR
Hippocampus
–CVR
+CVR
Pallidum
–CVR
+CVR
Putamen
–CVR
+CVR
CVR (%/mmHg)
–0.4 –0.3 –0.2 –0.1 0.0 0.1 0.2 0.3 0.4 0.5
Thalamus
–CVR
+CVR
White matter
–CVR
+CVR
Grey matter
–CVR
+CVR
Pre
Post
*
*
**
**
**
† †
† †
†
Figure 4. Displays the cerebral vascular reactivity (CVR) of different subcortical structures based on pretest positive CVR (+CVR) and negative
CVR (CVR) voxel masks. Negative CVR in the pretest was often reversed by exposure to high altitude. Few subjects demonstrated negative
reactivity when only considering voxels with a significant z-statistic (P < 0.05) in the pallidum, putamen, and thalamus limiting statistical power.
In all other structures, negative CVR was recorded in all subjects. Statistical symbols if marked on –CVR pre are statistically different from both
+CVR and CVR post. Alternatively, if statistical symbol is marked on CVR post the difference is compared to +CVR. *P < 0.05; **P < 0.01;
†P < 0.001.
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(Webster et al. 1995), is negative CVR detected in healthy
individuals the result of vascular steal? We studied a
group of young subjects with no history of cardiovascular
and respiratory disease. Voxels of negative CVR were pre-
sent in all anatomical structures including gray matter,
white matter, brainstem, nucleus accumbens, amygdala,
caudate, hippocampus, pallidum, putamen, and thalamus.
Interestingly, the magnitude of negative CVR was greatest
in the brainstem, an area with important chemosensitive
neurons and responsible for cardiovascular and respira-
tory control. As described above, we suspect that small
clusters of negative CVR, which are heterogeneously scat-
tered throughout the brain, are linked to the vascularity
or capillary density of a voxel. In this context, negative
CVR may reflect a capillary bed maximally dilated to
maintain adequate perfusion and is normally operating at
its vascular reserve (Sobczyk et al. 2014). However, fol-
lowing global hypoxia this region becomes stressed and is
able to normalize its response through the process of
angiogenesis and microvascular hyperplasia. An increase
in the BOLD response could in part be explained by hav-
ing more vessel volume in a given voxel and thus is some
evidence for angiogenesis. The mechanisms explaining
our observations are currently unknown, but likely
involve the complex interplay between hypoxia-induced
angiogenesis (LaManna et al. 1992), stimulation of neu-
ronal pathways, microvascular hyperplasia (Harik et al.
1995), release of adenosine, endothelium-derived nitric
oxide and a variety of autocoids and cytokines (reviewed
in: Ainslie and Ogoh 2010). These possibilities need to be
explored in future studies.
In contrast to voxels of negative CVR scattered
throughout the brain are focal regions of negative CVR.
Focal regions of negative CVR are more likely impacted
by downstream vessel disease impairing blood flow deliv-
ery to a much larger capillary network (Sobczyk et al.
Figure 5. An individual CVR response before and following high-altitude exposure. Displays cerebral vascular reactivity (CVR) maps and z-
statistic maps resel-corrected to P < 0.05 for one individual subject before (A) and following (B) exposure to high altitude. Note the decrease in
the degree of negative CVR following exposure to high altitude. The CVR for each voxel was then extracted and a fractional frequency
distribution at baseline and follow-up was generated to illustrate the reduction in voxels responding in the negative direction. The dotted
vertical lines mark the mean CVR for each distribution.
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2014). Regions of negative CVR in normal subjects are
typically found in regions of deep white matter (Mandell
et al. 2008) and thus it was surprising to observe signifi-
cant regions of negative CVR in otherwise healthy sub-
jects outside of deep white matter. Figure 5 illustrates a
large focal region of negative CVR in the right hemi-
sphere in one subject at baseline and follow-up. While
negative CVR could be an artifact of a poor correlation,
this seems unlikely since the z-statistic of voxels in these
regions reach statistical significance and the CVR stimulus
(i.e. PETCO2) was identical for pre and post tests (illus-
trated in Fig. 1). If CVR is plotted as a fractional fre-
quency distribution (see Fig. 5C) then it is possible to
observe how the distribution of CVR across the whole
brain is affected by high-altitude exposure. At baseline
prior to altitude exposure, the CVR is normally dis-
tributed with the majority of CVR being positive. How-
ever, following 3 weeks of altitude acclimatization and
return to sea level, the proportion of negative CVR scores
is dramatically reduced with a concomitant increase in
the frequency of positive CVR. This reduction in negative
CVR leads to an increase in the mean CVR. However,
considering the results from Figure 4, the increase in
mean CVR seems to be the result of a functional change
in regions of negative CVR rather than those regions of
the brain, which already responded in the expected posi-
tive manner.
Methodological considerations
Dehydration could be a confounder for the volumetric
and morphometric analyses conducted in this study. It
has previously been demonstrated using voxel-based mor-
phometry and longitudinal brain-change detection algo-
rithm’s (i.e., SIENA) that gray and white matter volume
measurements are associated with hydration status (Stre-
itb€urger et al. 2012). For example, dehydration led to sig-
nificant reductions in gray and white matter when using
voxel-based morphometry. Using this approach, signifi-
cant reductions in gray and white matter were found in
the left inferior orbito-frontal region, and in the extranu-
clear region. Interestingly, we did not detect any focal
changes in gray or white matter using a voxel-based mor-
phometry approach. Dehydration may have been a factor
while at high altitude, but at sea level it is likely that
hydration status was close to normal (Singh et al. 1990).
We used BOLD as a surrogate for cerebral blood flow,
which is well accepted (Hoge et al. 1999); however, CVR
obtained from BOLD is not comparable in magnitude to
CVR obtained by arterial spin labeling or Doppler ultra-
sound. In addition, the blood pressure response to CO2 is
an important confounding variable when assessing CVR
and we were unable to acquire blood pressure inside the
MRI and therefore cannot account for its effects on CVR
at follow-up. However, Smirl et al. (2014) assessed cere-
bral pressure-flow relationships before and following
high-altitude exposure in a set of subjects from the same
high-altitude expedition. Two weeks after return to sea
level hemodynamic and cardiovascular measures had
returned to baseline levels including spontaneous metrics
of cerebral pressure-flow relationships. Such findings indi-
cate that following high-altitude exposure the cerebral
autoregulation is normal.
This study is novel because it simultaneously addresses
the issue of brain volume and regional CVR before and
following 3 weeks of high-altitude acclimatization in the
Himalayas of Nepal in a small sample of healthy humans
(n = 6). The feasibility issues (i.e., cost, logistical)
involved in performing field research of this nature often
involve a trade-off in statistical power due to smaller
sample sizes. As argued in detail elsewhere (Ploutz-Snyder
et al. 2014) the value of small sample size research is
indeed appropriate when larger sample sizes are not feasi-
ble. We acknowledge that our sample size limits our abil-
ity to detect every region specific differences in brain
volume, WMHI and microhemorrhages and the related
relationships with CVR. However, we do present com-
pelling data in both mean and individual forms that
clearly demonstrates a consistent effect on total brain and
gray matter volume. More importantly, for the first time,
we illustrate a clear and significant effect of 3 weeks of
high-altitude exposure on regions of negative CVR, which
is consistent across all subjects and independent of
regions of positive CVR. These results are unlikely due to
methodological error as methodology and equipment
were identical at baseline and follow-up. Others have
reported the between-day coefficient of variation for CVR
to be 6.8  1.2% and 9.9  1.8% for gray and white
matter, respectively (Kassner et al. 2010). In addition, the
percent brain volume change normally has a 0.2% overall
error rate (Smith et al. 2007). Our principle effects are
outside the day-to-day measurement error. While our
data does not include a low altitude time control, and it
is possible that cardiovascular fitness may have improved
during the 8-day trek to high altitude, it seems unlikely
that this would have persisted during the 3 weeks at the
high-altitude research laboratory where participants led a
primarily sedentary lifestyle conducting and participating
in experiments.
Conclusion
We found that 1-week following return to sea level, brain
volume was significantly reduced and attributed to a loss
of gray matter tissue. In addition, our results highlight
the need to dichotomize regional CVR measurements into
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positive and negative responding units. By doing so we
found that regions of positive CVR were not impacted by
high-altitude exposure, but regions of negative CVR sig-
nificantly gained functionality.
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